How does Bromocriptine therapy alter the hypothalamic-pituitary axis in patients with endocrine dysfunction and what are its clinical implications?
Gaurav ChauhanContributor
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Bromocriptine therapy alter the hypothalamic-pituitary axis in patients with endocrine dysfunction and what are its clinical implications?
Bromocriptine inhibits prolactin secretion by activating dopamine receptors, thus reducing pituitary hormone output. It treats conditions like hyperprolactinemia and Parkinson’s.
Bromocriptine inhibits pituitary prolactin secretion, which can normalize prolactin levels, restoring fertility and reducing galactorrhea in prolactinoma patients.